
Audrey Cacaly MSc
Principal
Anaveon is a clinical stage, biopharmaceutical company, based in Switzerland, that develops biologics to modulate the function of cytokines and provide substantial therapeutic benefit to cancer patients.
The company's vision is to develop novel immune therapies benefiting patients suffering from a wide variety of diseases with immune pathology.
Industry
Biotech
Status
Current
Location
Switzerland